Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. (Q48232677)

9 February 2018

title

Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. (English)

1 reference

9 February 2018

1 reference

1

1 reference

9 February 2018

Alfons Schnitzler

12

1 reference

9 February 2018

Christoph Schrader

23

1 reference

9 February 2018

Günther Deuschl

3

Günther Deuschl

1 reference

9 February 2018

6

Werner Poewe

1 reference

PubMed ID

25127231

Kailash Phatechand Bhatia

9 February 2018

31

Kailash P Bhatia

1 reference

9 February 2018

7

Lars Timmermann

1 reference

9 February 2018

24

Manja Kloss

1 reference

9 February 2018

Marcus O. Pinsker

22

Marcus Pinsker

1 reference

9 February 2018

Joachim K. Krauss

5

Joachim K Krauss

1 reference

9 February 2018

Jürgen Voges

14

Jürgen Voges

1 reference

9 February 2018

Matthias Wittstock

16

Matthias Wittstock

1 reference

9 February 2018

Jerrold L Vitek

32

Jerrold L Vitek

1 reference

9 February 2018

author name string

Joerg Mueller

2

1 reference

9 February 2018

Andrea A Kühn

4

1 reference

9 February 2018

Daniela Falk

8

1 reference

9 February 2018

Andreas Kupsch

9

1 reference

9 February 2018

Anatol Kivi

10

1 reference

9 February 2018

Gerd-Helge Schneider

11

1 reference

9 February 2018

Martin Südmeyer

13

1 reference

9 February 2018

Alexander Wolters

15

1 reference

9 February 2018

Jan-Uwe Müller

17

1 reference

9 February 2018

Sascha Hering

18

1 reference

9 February 2018

Wilhelm Eisner

19

1 reference

9 February 2018

Jan Vesper

20

1 reference

9 February 2018

Thomas Prokop

21

1 reference

9 February 2018

Karl Kiening

25

1 reference

9 February 2018

Kai Boetzel

26

1 reference

9 February 2018

Jan Mehrkens

27

1 reference

9 February 2018

Inger Marie Skogseid

28

1 reference

9 February 2018

Jon Ramm-Pettersen

29

1 reference

9 February 2018

Georg Kemmler

30

1 reference

9 February 2018

Reiner Benecke

33

1 reference

9 February 2018

DBS study group for dystonia

34

1 reference

9 February 2018

publication date

7 August 2014

1 reference

9 February 2018

published in

Lancet Neurology

1 reference

9 February 2018

volume

13

1 reference

9 February 2018

page(s)

875-884

1 reference

9 February 2018

issue

9

1 reference

9 February 2018

A prevalence study of primary dystonia in eight European countries

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Prevalence of cervical dystonia and spasmodic torticollis in the United States general population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Epidemiology of focal and generalized dystonia in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

What are the determinants of quality of life in people with cervical dystonia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Impact of cervical dystonia on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

The impact of blepharospasm and cervical dystonia on health-related quality of life and depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

EFNS guidelines on diagnosis and treatment of primary dystonias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Pallidal deep-brain stimulation in primary generalized or segmental dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Deep brain stimulation for cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Pallidal deep brain stimulation in cervical dystonia: clinical outcome in four cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Bilateral deep brain stimulation for cervical dystonia: long-term outcome in a series of 10 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Selective peripheral denervation: comparison with pallidal stimulation and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

The Canadian multicentre study of deep brain stimulation for cervical dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Phenomenology and classification of dystonia: a consensus update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Good long-term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer-blinded study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Deep brain stimulation for generalised dystonia and spasmodic torticollis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Subthalamic nucleus deep brain stimulation in primary cervical dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Dystonia rating scales: critique and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

Induction of bradykinesia with pallidal deep brain stimulation in patients with cranial-cervical dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

GPi-DBS may induce a hypokinetic gait disorder with freezing of gait in patients with dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970143-7

7 January 2021

10.1016/S1474-4422(14)70143-7

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

25127231

1 reference

9 February 2018